Subscribe

Doris Hansen, MD

Articles by Doris Hansen, MD

Doris Hansen, MD

The Potential of ALLO-715 in Relapsed/Refractory Multiple Myeloma: Doris Hansen, MD

ByDoris Hansen, MD

October 25th 2021

The hematologist from Moffitt Cancer Center discussed the promise of ALLO-715 in relapsed/refractory multiple myeloma.

Doris Hansen, MD

Ide-Cel's Benefit on PF Survival: Doris Hansen, MD

ByDoris Hansen, MD

October 16th 2021

The hematologist from Moffitt Cancer Center discussed the survival benefit of ide-cel in the phase 2 KarMMa trial.

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

© 2025 MJH Life Sciences^®

All rights reserved.